Velcade Side Effects
View Community-reported Velcade side effects
Add Your Side Effect to the Community Database
Help Community - Describe Your Velcade Side Effect
Have You dealt with a Velcade side effect? Share your experience
Velcade Side Effects summary
Total Velcade reports: 2239.Velcade FDA safety alerts: No.
Reported deaths: 746 Reported hospitalizations: 1286.
Take Velcade Side Effects Survey, Discuss Velcade with others
Velcade Side Effects: diarrhoea, thrombocytopenia, pyrexia, disease progression, asthenia, neuropathy peripheral, platelet count decreased, hypotension, blood lactate dehydrogenase increased, atrial fibrillation, nausea,
Velcade Usage.
If you have questions about Velcade, you can ask a Health Expert or Ask Patient Community about Velcade.
Self-reported VELCADE Side Effects
Velcade Side Effects Report #SELF464 -2008-06-01
VELCADE problem was reported on 2008-06-01
Patient reported the following VELCADE side effects:"\""ACUTE, CRONIC, SEVERE\"" NEUROPATHY (words of neurologist)Had transplant Aug. 08 and it has NOT improved- numb feet & lower legs/fingers - sometimes extreme pain (today\'s date Nov. 7,08"Read more
Velcade Side Effects reported to FDA
< Previous Showing 121-160 of 2239 Next >
Velcade Side Effects Report #5691735-1Physician from UNITED STATES reported VELCADE problem on Mar 12, 2008. Male patient, 68 years of age, weighting 179.7 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: chest pain. VELCADE dosage: 1.30 MG/M2 , INTRAVENOUS. During the same period patient was treated with DOXIL, THALIDOMIDE. Patient was hospitalized. Patient recovered.
Velcade Side Effects Report #5691736-3
VELCADE problem was reported by a Physician from UNITED STATES on Mar 24, 2008. Female patient, 45 years of age, was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: anaemia, congestive cardiomyopathy, contusion, fall, full blood count abnormal, leukocytosis, marrow hyperplasia, thrombocytopenia. VELCADE dosage: unknown. During the same period patient was treated with DOXORUBICIN. Patient recovered.
Velcade Side Effects Report #5691893-9
Physician from JAPAN reported VELCADE problem on Jan 08, 2008. Male patient, 62 years of age, weighting 183.0 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: bronchial haemorrhage, cardiac failure, cardiomegaly, pneumonia. VELCADE dosage: 1.30 MG/KG, INTRAVENOUS, 1.00 MG/M2 INTRAVENOUS. Patient recovered.
Velcade Side Effects Report #5691896-4
VELCADE problem was reported by a Consumer or non-health professional from JAPAN on Mar 18, 2008. Male patient, 61 years of age, weighting 149.9 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: anaemia, constipation, neuropathy peripheral, pain in extremity, platelet count decreased. VELCADE dosage: 1.30 MG/M2, INTRAVENOUS, 2.29 MG, INTRAVENOUS. During the same period patient was treated with ZOMETA, PLATELETS, FAMOTIDINE. Patient recovered.
Velcade Side Effects Report #5691913-1
Physician from FRANCE reported VELCADE problem on Mar 17, 2008. Male patient, 57 years of age, weighting 174.2 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: pneumococcal infection. VELCADE dosage: 1.30 MG/M2, UNK, INTRAVENOUS. During the same period patient was treated with THALIDOMIDE, DEXAMETHASONE, CLODRONIC ACID, LYSINE ACETYLSALICYLATE, LOPERAMIDE. Patient was hospitalized. Patient died on 03/02/2008.
Velcade Side Effects Report #5691914-3
VELCADE problem was reported by a Physician from KOREA, REPUBLIC OF on Mar 18, 2008. Female patient, 79 years of age, weighting 103.6 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: pneumonia, septic shock. VELCADE dosage: 1,3 MG/M2, UNK, INTRAVENOUS. Patient died on 06/07/2007.
Velcade Side Effects Report #5691915-5
Physician from JAPAN reported VELCADE problem on Mar 18, 2008. Male patient, 58 years of age, weighting 125.7 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: abdominal pain upper, anaemia, anorexia, diarrhoea, disease progression, hypoalbuminaemia, hyponatraemia, insomnia, malignant pleural effusion. VELCADE dosage: 2.20 MG UNK INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, SULFAMETHOXAZOLE AND TRIMETHOPRIM, SELBEX, ALLOPURINOL, FAMOTIDINE, NORVASC, ATARAX, DIFLUCAN. Patient died on 10/20/2007.
Velcade Side Effects Report #5691916-7
VELCADE problem was reported by a Physician from JAPAN on Mar 20, 2008. Female patient, 51 years of age, weighting 121.3 lb, was diagnosed with multiple myeloma, prophylaxis and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: anaemia, blood albumin decreased, blood lactate dehydrogenase increased, blood sodium decreased, c-reactive protein increased, disease progression, hepatic function abnormal, hypercalcaemia, lymphocyte count decreased. VELCADE dosage: 1.91 MG UNK INTRAVENOUS. During the same period patient was treated with SULFAMETHOXAZOLE, PROTECADIN, LAMIVUDINE, OXYCONTIN, CEFZON, CALONAL, LAXOPERON, ROCEPHIN. Patient died on 01/23/2008.
Velcade Side Effects Report #5691920-9
Physician from JAPAN reported VELCADE problem on Feb 19, 2008. Female patient, 61 years of age, weighting 112.4 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: disease progression, hypotension. VELCADE dosage: 1.30 MG/MG, UNK, INTRAVENOUS. During the same period patient was treated with MUCOSTA, GASMOTIN, DIFLUCAN, ZOVIRAX, CLARITHROMYCIN, OMEPRAL, PYRINAZIN. Patient died on 01/14/2008.
Velcade Side Effects Report #5691921-0
VELCADE problem was reported by a Physician from JAPAN on Feb 14, 2008. Male patient, 63 years of age, weighting 125.7 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: aspartate aminotransferase increased, blood lactate dehydrogenase increased, blood uric acid increased, disease progression, multiple myeloma, platelet count decreased. VELCADE dosage: 2.00 MG UNK INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, VANCOMYCIN, ADONA, MUCOSOLVAN, LANSOPRAZOLE, ITRACONAZOLE, MAGNESIUM OXIDE, OXYCONTIN. Patient died on 01/14/2008.
Velcade Side Effects Report #5691922-2
Physician from JAPAN reported VELCADE problem on Mar 19, 2008. Female patient, 68 years of age, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: altered state of consciousness, dysarthria, dysstasia, encephalitis herpes. VELCADE dosage: 1.30 MG/M2 UNK INTRAVENOUS. Patient recovered.
Velcade Side Effects Report #5691927-1
VELCADE problem was reported by a Physician from ITALY on Mar 19, 2008. Male patient, 77 years of age, weighting 154.3 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: atrial fibrillation, electrocardiogram t wave inversion, syncope. VELCADE dosage: unknown. During the same period patient was treated with THALIDOMIDE, MELPHALAN, PREDNISONE. Patient was hospitalized. Patient recovered.
Velcade Side Effects Report #5691929-5
Health Professional from COLOMBIA reported VELCADE problem on Mar 19, 2008. Male patient, 69 years of age, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: back pain, dehydration, diarrhoea, vomiting. VELCADE dosage: 1.00 MG/M2, INTRAVENOUS. During the same period patient was treated with ZOMETA. Patient was hospitalized. Patient died on 03/14/2008.
Velcade Side Effects Report #5615259-2
VELCADE problem was reported by a Physician from SPAIN on Jan 22, 2008. Female patient was diagnosed with multiple myeloma and was treated with VELCADE. VELCADE dosage: 1.30 MG/M2, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE. Patient died.
Velcade Side Effects Report #5615260-9
Health Professional from UNITED STATES reported VELCADE problem on Jan 23, 2008. Male patient, child 1 years of age, weighting 165.8 lb, was diagnosed with acute lymphocytic leukaemia and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: cellulitis, chest pain, dyspnoea, staphylococcal infection. VELCADE dosage: 1.00 MG/M2, INTRAVENOUS. During the same period patient was treated with ZAMESTRA, LEVAQUINN, NEUPOGEN. Patient was hospitalized. Patient recovered.
Velcade Side Effects Report #5615261-0
VELCADE problem was reported by a Physician from SPAIN on Jan 22, 2008. Female patient was diagnosed with leukaemia plasmacytic and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: disease progression. VELCADE dosage: 1.30 MG/M2,. Patient died.
Velcade Side Effects Report #5615262-2
Physician from UNITED STATES reported VELCADE problem on Jan 24, 2008. Male patient, 69 years of age, weighting 205.3 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: colitis, nausea. VELCADE dosage: 1.00 MG/M2. During the same period patient was treated with DEXAMETHASONE, THALIDOMIDE, CISPLATIN, DOXORUBICIN. Patient was hospitalized. Patient recovered.
Velcade Side Effects Report #5615687-5
VELCADE problem was reported by a Physician from SPAIN on Jan 22, 2008. Female patient was diagnosed with multiple myeloma and was treated with VELCADE. VELCADE dosage: 1.30 MG/M2. During the same period patient was treated with DEXAMETHASONE. Patient died.
Velcade Side Effects Report #5615688-7
Physician from SPAIN reported VELCADE problem on Jan 22, 2008. Female patient, child -1 years of age, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: leukaemia plasmacytic. VELCADE dosage: 1.30 MG/M2, INTRAVENOUS. Patient died.
Velcade Side Effects Report #5615692-9
VELCADE problem was reported by a Physician from JAPAN on Jan 23, 2008. Female patient, 73 years of age, weighting 134.5 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: capillary leak syndrome, tumour lysis syndrome. VELCADE dosage: unknown. Patient was hospitalized. Patient recovered.
Velcade Side Effects Report #5615693-0
Physician from JAPAN reported VELCADE problem on Jan 22, 2008. Male patient, 71 years of age, weighting 105.8 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, basophil count decreased, blood alkaline phosphatase decreased, blood lactate dehydrogenase increased, blood urea increased, blood uric acid increased, c-reactive protein increased, febrile neutropenia. VELCADE dosage: 1.00 MG/M2, INTRAVENOUS; 1.40 MG, INTRAVENOUS. During the same period patient was treated with ZOMETA, BICARBONATE, NEUTROGIN, AMIKACIN SULPHATE, LASIX, VORICONAZOLE, RABEPRAZOLE. Patient died on 05/07/2007.
Velcade Side Effects Report #5615694-2
VELCADE problem was reported by a Physician from JAPAN on Jan 23, 2008. Male patient, 66 years of age, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: anaemia, anorexia, blood alkaline phosphatase increased, blood urea increased, disease progression, hypotension, nausea, platelet count decreased, pneumonia. VELCADE dosage: 2.20 MG,. During the same period patient was treated with DEXAMETHASONE, DIGOXIN, VOLTAREN, MAGNESIUM OXIDE, CYTOTEC, PURSENNID, LANSOPRAZOLE, AMITRIPTYLINE. Patient was hospitalized. Patient died on 06/11/2007.
Velcade Side Effects Report #5615698-X
Physician from JAPAN reported VELCADE problem on Jan 23, 2008. Male patient, 62 years of age, weighting 167.6 lb, was diagnosed with multiple myeloma, sepsis and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: abdominal distension, cytomegalovirus infection, enteritis infectious, fungus serology test positive, hypoalbuminaemia, ileus, neuropathy peripheral, orthostatic hypotension, rash. VELCADE dosage: 2.4 MG, INTRAVENOUS; 1.90 MG, INTRAVENOUS. During the same period patient was treated with PRODIF, DEXAMETHASONE, GRANISETRON, BETAMETHASONE BUTYRATE PROPIONATE, EXACIN, CEFAMEZOL, ALBUMIN. Patient was hospitalized. Patient died on 11/25/2007.
Velcade Side Effects Report #5615699-1
VELCADE problem was reported by a Physician from JAPAN on Jan 22, 2008. Male patient, 77 years of age, weighting 143.3 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: blood creatinine increased, blood urea abnormal, disease progression, dyspnoea, metabolic acidosis, oedema, tumour lysis syndrome, weight increased. VELCADE dosage: 1.60 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, FAMOTIDINE, SELBEX, BAKTAR, ALLOPURINOL, METHYCOBAL. Patient died on 08/03/2007.
Velcade Side Effects Report #5616263-0
Physician from UNITED STATES reported VELCADE problem on Jan 23, 2008. Male patient, 65 years of age, weighting 239.2 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: bacteraemia, bacterial toxaemia, blood pressure decreased, clostridium difficile colitis, fungaemia, haemodialysis, hypoxia, lung disorder. VELCADE dosage: 1.30 MG/M2, INTRAVENOUS. During the same period patient was treated with RITUXAN, ETOMIDATE, METHOTREXATE, MELPHALAN, ETOPOSIDE, CYTARABINE, CARMUSTINE. Patient died on 12/31/2007.
Velcade Side Effects Report #5616264-2
VELCADE problem was reported by a Physician from UNITED STATES on Jan 25, 2008. Male patient, 55 years of age, weighting 209.0 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: convulsion, encephalitis, loss of consciousness, mental status changes. VELCADE dosage: unknown. During the same period patient was treated with NIASPAN, VYTORIN, COREG, NEXIUM, ALLOPURINOL, REGLAN, MAGNESIUM, VITAMINS. Patient was hospitalized. Patient recovered.
Velcade Side Effects Report #5616265-4
Physician from UNITED STATES reported VELCADE problem on Jan 25, 2008. Male patient, 72 years of age, weighting 189.4 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: convulsion, fatigue, hypotension, unresponsive to stimuli. VELCADE dosage: 2.50 MG, INTRAVENOUS. During the same period patient was treated with ALLOPURINOL, INSULIN, HYZAAR. Patient was hospitalized. Patient recovered.
Velcade Side Effects Report #5617247-9
VELCADE problem was reported by a Physician from JAPAN on Jan 24, 2008. Male patient, 60 years of age, weighting 169.8 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: neurogenic bladder. VELCADE dosage: 2.30 MG, INTRAVENOUS; 1.30 MG/M2, INTRAVENOUS. During the same period patient was treated with TIZANIDINE, MUCOSTA, OMEPRAZOLE, AMLODIPINE BESYLATE, OLMETEC, TAMSULOSIN, UBRETID. Patient recovered.
Velcade Side Effects Report #5617248-0
Physician from PORTUGAL reported VELCADE problem on Jan 30, 2008. Female patient, 85 years of age, weighting 147.7 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: bradycardia, cardio-respiratory arrest, cerebral ischaemia, cerebrovascular accident, coma, encephalopathy, spinal cord disorder, ventricular fibrillation. VELCADE dosage: 1.30 MG.M2, INTRAVENOUS. During the same period patient was treated with FUROSEMIDE, LANOXIN, TICLOPIDINE, DARBEPOETIN ALFA, PAMIDRONATE DI. Patient was hospitalized. Patient recovered.
Velcade Side Effects Report #5617250-9
VELCADE problem was reported by a Physician from JAPAN on Jan 24, 2008. Male patient, 65 years of age, weighting 130.1 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: aspartate aminotransferase increased, hepatic function abnormal, herpes zoster, hypoaesthesia, nausea, platelet count decreased, pyrexia, urinary tract infection. VELCADE dosage: 1.00 MG/M2, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, PRIMPERAN, BAKTAR, CIPROFLOXACIN, BASEN, AMARYL, LANSOPRAZOLE, MAGNESIUM OXIDE. Patient recovered.
Velcade Side Effects Report #5617253-4
Physician from JAPAN reported VELCADE problem on Jan 24, 2008. Male patient, 64 years of age, weighting 138.9 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: abdominal pain, anaemia, ascites, cholecystitis chronic, diarrhoea, hypoaesthesia, oedema peripheral, platelet count decreased. VELCADE dosage: 1.90 MG, INTRAVENOUS; 1.50MG, INTRAVENOUS. During the same period patient was treated with DECADRON, LASIX, DEXAMETHASONE, KYTRIL, BICARBONATE, FAMOTIDINE. Patient was hospitalized. Patient recovered.
Velcade Side Effects Report #5617255-8
VELCADE problem was reported by a Physician from JAPAN on Jan 23, 2008. Male patient, 75 years of age, weighting 127.9 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: anorexia, antibody test positive, bronchiectasis, condition aggravated, constipation, diarrhoea, hypertension, interstitial lung disease, movement disorder. VELCADE dosage: 2.20 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, ALFAROL, PURSENNID, MAGNESIUM OXIDE, LANSOPRAZOLE, KYTRIL, POLYETHYLENE GLYCOL, LOPERAMIDE. Patient was hospitalized and became disabled. Patient recovered.
Velcade Side Effects Report #5621662-7
Health Professional from UNITED STATES reported VELCADE problem on Jan 28, 2008. Male patient, 57 years of age, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: disease progression. VELCADE dosage: unknown. During the same period patient was treated with DOXIL, ZOMETA. Patient was hospitalized. Patient died on 01/24/2008.
Velcade Side Effects Report #5621664-0
VELCADE problem was reported by a Health Professional from UNITED STATES on Jan 29, 2008. Female patient, 63 years of age, weighting 160.1 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: cough, rales, respiratory disorder, wheezing. VELCADE dosage: 1.00 MG/M2, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, COMBIVENT, MS CONTIN, PROCARDIA, ATENOLOL, DILANTIN, ZOCOR, NORTRIPTYLINE. Patient was hospitalized. Patient recovered.
Velcade Side Effects Report #5622317-5
Pharmacist from FRANCE reported VELCADE problem on Jan 28, 2008. Female patient, 77 years of age, weighting 121.3 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: gastrointestinal necrosis, peritonitis. VELCADE dosage: 1.30 MG/M2, INTRAVENOUS. During the same period patient was treated with PREVISCAN, OMEPRAZOLE, BISOPROLOL FUMARATE, BISOPROLOL FUMARATE, DEXAMETHASONE. Patient was hospitalized. Patient recovered.
Velcade Side Effects Report #5622320-5
VELCADE problem was reported by a Physician from GERMANY on Jan 25, 2008. Female patient, weighting 149.9 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: herpes simplex, pain, vomiting. VELCADE dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, DEXAMETHASONE, NATRIUM GENTISICUM, GRANISETRON, HYDROMORPHONE, ACETAMINOPHEN, ESOMEPRAZOLE. Patient was hospitalized. Patient recovered.
Velcade Side Effects Report #5622323-0
Physician from JAPAN reported VELCADE problem on Jan 25, 2008. Female patient, 65 years of age, weighting 77.16 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: cytomegalovirus infection, diarrhoea, disease progression, gastritis, hypokalaemia, malaise, nasopharyngitis, orthostatic hypotension, shock. VELCADE dosage: 1.65 MG, INTRAVENOUS : 1.29 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, FUNGUARD, MEROPEN, TARGOCID, MINOCYCLINE, IMMUNE GLOBULIN. Patient was hospitalized. Patient died on 08/20/2007.
Velcade Side Effects Report #5622325-4
VELCADE problem was reported by a Physician from JAPAN on Jan 25, 2008. Male patient, 69 years of age, weighting 152.1 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: cytomegalovirus infection. VELCADE dosage: 2.30 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, LANSOPRAZOLE, BAKTAR, SELBEX, PURSENNID, MAGNESIUM, CEFEZOLIN, EXACIN. Patient was hospitalized. Patient recovered.
Velcade Side Effects Report #5622327-8
Physician from JAPAN reported VELCADE problem on Jan 25, 2008. Male patient, 73 years of age, weighting 138.9 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: constipation, disease progression, hypoaesthesia, platelet count decreased, rash. VELCADE dosage: 2.00 MG, INTRAVENOUS : 1.50 MG, INTRAVENOUS : 1.00 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, LOXOPROFEN, MUCOSTA, FLUCONAZOLE, BAKTAR, MAGNESIUM OXIDE. Patient died on 01/06/2008.
Velcade Side Effects Report #5622911-1
VELCADE problem was reported by a Physician from JAPAN on Jan 28, 2008. Male patient, 60 years of age, weighting 141.1 lb, was diagnosed with multiple myeloma, pain and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, c-reactive protein increased, disease progression, diverticulum intestinal haemorrhagic, haemoglobin decreased, malaise, melaena, multiple myeloma. VELCADE dosage: 2.2 MG, INTRAVENOUS. During the same period patient was treated with ETODOLAC, PREDNISOLONE, TEGRETOL, MEXITIL, MAGNESIUM OXIDE, FAMOTIDINE, ALLOPURINOL, FENTANYL. Patient died on 01/04/2008.
< Previous Showing 121-160 of 2239 Next >